Colgate-Palmolive (NYSE: CL) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Earnings & Valuation

This table compares Colgate-Palmolive and DS Healthcare Group’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Colgate-Palmolive $15.20 billion 4.22 $2.44 billion $2.59 28.20
DS Healthcare Group $12.95 million 0.02 -$6.93 million ($0.27) -0.04

Colgate-Palmolive has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Colgate-Palmolive, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Colgate-Palmolive and DS Healthcare Group, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Colgate-Palmolive 1 12 4 0 2.18
DS Healthcare Group 0 0 0 0 N/A

Colgate-Palmolive currently has a consensus price target of $75.50, indicating a potential upside of 3.37%. Given Colgate-Palmolive’s higher possible upside, equities analysts plainly believe Colgate-Palmolive is more favorable than DS Healthcare Group.

Volatility and Risk

Colgate-Palmolive has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500.

Insider and Institutional Ownership

73.2% of Colgate-Palmolive shares are held by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are held by institutional investors. 1.0% of Colgate-Palmolive shares are held by insiders. Comparatively, 19.4% of DS Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Colgate-Palmolive pays an annual dividend of $1.60 per share and has a dividend yield of 2.2%. DS Healthcare Group does not pay a dividend. Colgate-Palmolive pays out 61.8% of its earnings in the form of a dividend. Colgate-Palmolive has increased its dividend for 53 consecutive years.


This table compares Colgate-Palmolive and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Colgate-Palmolive 15.10% 2,782.56% 20.45%
DS Healthcare Group -62.31% -1,304.25% -117.85%


Colgate-Palmolive beats DS Healthcare Group on 12 of the 15 factors compared between the two stocks.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company’s oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy’s Oil Soap. The Company, through its Hill’s Pet Nutrition segment (Hill’s), manufactures pet nutrition products for dogs and cats.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.